Skip to main content
Top

Lung

Issue 2/2008

Content (8 Articles)

Clinical Outcome of Stage III Non-small-cell Lung Cancer Patients After Definitive Radiotherapy

Tatsuya Nakamura, Nobukazu Fuwa, Takeshi Kodaira, Hiroyuki Tachibana, Takuya Tomoda, Rie Nakahara, Haruo Inokuchi

Predicting Survival in Potentially Curable Lung Cancer Patients

Thida Win, Linda Sharples, Ashley M. Groves, Andrew J. Ritchie, Francis C. Wells, Clare M. Laroche

Peroxiredoxin V Contributes to Antioxidant Defense of Lung Epithelial Cells

Pedro C. Avila, Andrei V. Kropotov, Raisa Krutilina, Anna Krasnodembskay, Nikolay V. Tomilin, Vladimir B. Serikov

Bronchial Responsiveness During Esophageal Acid Infusion

Ana Carla S. Araujo, Lílian Rose O. Aprile, Roberto O. Dantas, João Terra-Filho, Elcio O. Vianna

Lung Images: Primary Pulmonary Hemangiopericytoma

Sami Karapolat, Ahmet Onen, Aydin Sanli

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine